Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.

Transfusion medicine (Oxford, England) - 1 Jun 1998

Daniels G L, Green C A, Mallinson G, Okubo Y, Hori Y, Kataoka A, Kaihara M

Abstract excerpt

Decay-accelerating factor (DAF, CD55) is a complement regulatory glycoprotein that expresses the Cromer-system blood group antigens. Two, very rare, inherited DAF-deficiency phenotypes, Inab and Dr(a-), were identified in Japanese propositi. Red cells of the Inab phenotype propositus had no Cromer-system antigens and did not bind monoclonal anti-DAF. The Inab propositus was homozygous for a DAF non-sense...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Group Antigens
Share to Child
Share to Erythrocytes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Heterozygote

Share to Homozygote

Share to Mutation

Share to Phenotype

Source

Identifiers

PMID: 9675792
DOI: 10.1046/j.1365-3148.1998.00145.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.PMID 9675792Read ↗

Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype.Semantic proximity Read ↗

Novel molecular basis of an Inab phenotype.Semantic proximity Read ↗

Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.Semantic proximity Read ↗

Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency).Semantic proximity Read ↗

Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.Semantic proximity Read ↗

Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC.Semantic proximity Read ↗

Case report and literature review: transient Inab phenotype and an agglutinating anti-IFC in a patient with a gastrointestinal problem.Semantic proximity Read ↗

Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.Semantic proximity Read ↗

Conservation in decay accelerating factor (DAF) structure among primates.Semantic proximity Read ↗

Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement RegulationSemantic proximity Read ↗

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.Semantic proximity Read ↗

Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.